Barclays maintains Snowflake stock rating after CRO change

Jonathan Beaulier was appointed Snowflake CRO effective immediately and the company reaffirmed Q1 FY2027 and full-year FY2027 guidance. Barclays reiterated an Equalweight rating with a $192 price target while SNOW trades at $150.82 (roughly 32% down over six months) and InvestingPro fair value sits at $166.82, implying some undervaluation. Morgan Stanley (Overweight) and Stifel (Buy) also reiterated positive views, citing AI product momentum (including Cortex Code) and low penetration upside, and Barclays said the new CRO is well-aligned with Snowflake's AI-focused go-to-market pivot.

Analysis

Snowflake’s pivot to an AI-centered go-to-market is a classic growth-company inflection: the real lever is not product novelty but converting AI experimentation into recurring billable units (new workloads + higher seat counts). If the company can increase average revenue per customer by 10–25% over 12–18 months via developer-led onboarding and transactional capabilities, the reorg will be accretive; failure will show up as longer sales cycles and step-ups in churn metrics.

Second-order winners are ecosystem players that monetize increased cloud consumption (storage/compute providers and data-integration vendors) while losers include incumbent analytics incumbents who monetize legacy ETL and custom pipelines. But a hidden cost is cloud-provider economics: materially higher customer consumption can compress Snowflake’s gross margin unless offset by pricing power or pass-through contracts — watch billings vs realized gross margins over the next two quarters.

Key risks and catalysts: near-term is execution risk around sales re-sizing and messaging (days–quarters), medium-term is product-market evidence of Cortex/transactional workloads converting trials into ARR (quarters–12 months), and tail risks include data residency/regulatory pushback or macro slowdowns that delay enterprise AI budgets. The market will re-rate the story rapidly on two data points: sequential acceleration in net new ARR in the next two quarters and clear evidence of margin recovery at scale.

Key Decisions for Investors

• Directional, defined-risk long: Buy a 12–18 month SNOW call spread (1x ATM long call, 1x 25–35% OTM short call) sized so premium = 5–8% of portfolio risk. Rationale: captures multi-quarter adoption while capping downside to premium; target ~2.0–3.0x return if product adoption accelerates and ARR inflection is visible within 12 months.
• Core equity with financed carry: Accumulate SNOW stock on down days to a 6–12 month horizon, finance ~30–50% of position by selling 3–4 month covered calls at strikes ~20–30% above purchase to reduce basis. Risk control: trim if position falls 20% from cost or if sequential net new ARR misses two consecutive quarters; reward: asymmetric upside if AI monetization proofs out.
• Event hedge (crash protection): Buy 2–3 month OTM puts (10–15% OTM) ahead of the next earnings/guide cadence as inexpensive insurance. This limits downside to premium and provides >2–3x payoff on a significant guidance miss or reorg-driven revenue miss.
• Volatility/Income trade: If implied vol spikes into a catalyst window, sell a defined-risk iron condor 30–45 days out using strikes that leave ~10–15% buffer each way, sizing max loss to no more than 2x collected premium. This captures premium if the market waits for proof and remains rangebound, but exit immediately on >10% gap move.